Respiratory syncytial virus
CA 2450131 A1 · Owner: Medical Research Council · Inventors: Yeo, Robert Paul
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Respiratory syncytial virus, or RSV, is a cause of respiratory tract infection in humans and other animals. Replication of the virus relies in part upon the association of the nucleocapsid (N) protein with a phosphoprotein (P protein). The present invention describes the identification and sequencing of peptide fragments which bind to the P protein and which disrupt the interaction of the N and P proteins. Such peptides may be used to inhibit replication of RSV and , for treatment of patients infected with RSV. Further aspects of the invention relate to the use of such peptides in the diagnosis of RSV infection.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 14, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 14, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 14, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.